|
|
SPOT ON
|
|
New US cholesterol guideline: a paradigmatic change?
|
|
|
NEW ON THE MARKET
|
|
Teriflunomide (AUBAGIO) against multiple sclerosis
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Preference of live attenuated influenza vaccine in 2 to 6 year old children?
HPV-based cervical cancer screening
|
|
|
a-t READERS' QUESTIONS AND COMMENTS
|
|
Hydroxyethyl starch against sudden hearing loss?
Breast cancer with the progestogen-containing intrauterine device MIRENA
|
|
|
IN BRIEF
|
|
Heavily advertised and often bought - irrational fixed combinations against common cold
|
|
Restriction of use of hydroxyethyl starch instead of withdrawal from the market
Calcium-free phosphate binders in patients with renal insufficiency
Market research with brain scans
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Liver damage with rivaroxaban (XARELTO)
|
|
|
SIDE EFFECTS
|
|
Haemophagocytic syndrome with the multiple sclerosis drug fingolimod (GILENYA)
|
|